Evaluation of antipruritic effects of serlopitant, a neurokinin 1 receptor antagonist, in patients with epidermolysis bullosa: A phase 2 randomized controlled trialJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGYIF82024-07-010PRE
Classification of 2 distinct wound types in recessive dystrophic epidermolysis bullosa: A retrospective and cohort natural history studyJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82021-11-0115OAAI
Measurement of skin adhesion in recessive dystrophic epidermolysis bullosa patientsJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82021-08-011OAAI
Validity and accuracy of a mobile phone application for the assessment of wounds in recessive dystrophic epidermolysis bullosaJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82021-08-010OAAI
Phase 2 trial of a neurokinin-1 receptor antagonist for the treatment of chronic itch in patients with epidermolysis bullosa: A randomized clinical trialneurokinin-1受体拮抗剂治疗大疱性表皮松解症患者慢性瘙痒的2期临床试验: 一项随机临床试验JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82020-06-0134OAAI
Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosaJCI INSIGHTIF6.12019-10-0386OA
Phase 2 trial of a neurokinin-1 receptor antagonist for the treatment of chronic itch in epidermolysis bullosa patientsJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72018-05-011OAAI
50% wound healing correlates with RDEB patient reported outcomes in pain, itch and skin durabilityJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72018-05-012OAAI
Defining chronic wound types in recessive dystrophic epidermolysis bullosa patients for clinical outcome assessmentJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72018-05-012OAAI
Natural history of chronic wounds in patients with recessive dystrophic epidermolysis bullosaJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72017-05-012OAAI
Quality of life in recessive dystrophic epidermolysis bullosa: The AltaVoice patient registry, 2012-2015JOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72017-05-015OAAI
Validity and accuracy of a mobile phone application for the assessment of chronic wounds in recessive dystrophic epidermolysis bullosaJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72017-05-010OAAI